期刊文献+

老年人非小细胞肺癌35例手术治疗临床分析 被引量:2

Clinical analysis of surgical treatment for the aged patients with primary NSCLC: a report of 35 cases
原文传递
导出
摘要 目的分析老年非小细胞肺癌(NSCLC)患者术后并发症的可能危险因素,探讨围术期的处理措施,以提高手术治疗效果。方法回顾性分析35例老年NSCLC患者的临床资料,对术后并发症的可能危险因素先进行单因素分析,有统计学意义者纳入Logistic回归分析。结果35例患者术后发生各种并发症10例,占28.6%;死亡1例,占2.9%。Logistic回归分析提示慢性支气管炎史、吸烟史、冠心病史、结核病史、第一秒用力呼气容积(FEV1)、肺叶切除、手术方式是术后并发症的独立危险因素(均P〈0.05)。结论正确进行手术前分期,严格掌握手术适应证,选择规范的手术方法,降低手术创伤,加强围术期管理,对老年非小细胞肺癌患者实施外科手术仍能达到令人满意的治疗效果。 Objective To investigate the clinical feature of perioperative management of non-small cell lung eancer(NSCLC) in aged patients and improve the efficacy of surgical treatment. Methods The clinical data of 35 aged patients' with NSCLC were retrospectively analyzed. The risk factors of postoperative complications were analyzed by single factor analysis, the factors had statistical significance were included in Logistic regression analysis. Results Postoperative complications occurred in 10 cases, accounting for 28.6%, and 1 case died, accounting for 2. 9%. Logistic regression analysis showed that smoking, chronic bronchitis, coronary heart disease ,pulmonary lobecto- my were independent risk factors of postoperative complications. Conclusion Correct staging before operation, strict surgical indication, choose the standard surgical method to reduce surgical trauma, strengthen the perioperative management can still achieve satisfactory therapeutic effect in surgical operation for aged patients with NSCLC.
出处 《中国基层医药》 CAS 2013年第14期2139-2141,共3页 Chinese Journal of Primary Medicine and Pharmacy
关键词 非小细胞肺 老年人 外科手术 Carcinoma non-small-cell lung Aged Surgical procedures
  • 相关文献

参考文献13

二级参考文献62

共引文献106

同被引文献25

  • 1许川,梅宏,韩连奎,李震宇,刘波,刘迪.早期周围型非小细胞肺癌患者纵隔淋巴结转移的危险因素[J].中国老年学杂志,2014,34(12):3274-3275. 被引量:4
  • 2张维维,唐敏,费玲.抗血管生成药物联合化疗治疗进展期非小细胞肺癌研究现状[J].现代生物医学进展,2011,11(S1):4796-4800. 被引量:4
  • 3王洁.晚期非小细胞肺癌化疗进展[C]//中华医学会第五届全国胸部肿瘤及内窥镜学术会议论文汇编,北京:人民隆重出版社.2011.
  • 4Brambilla E ,Travis WD, Colby TV, et al. The new World Health Organization classification of lung tumours [ J ]. Eur Respir J, 2001,18 (6) : 1059-1068.
  • 5Duffaud F, Therasse P. New guidelines to evaluate the response to treatment in solid tumors [ J ]. Bull Cancer, 2000,87 ( 12 ) : 881- 886.
  • 6Noh J, Kim J, Ahn Y, et al. Effect of radiation therapy techniques on outcome in N3-positive IIIB non-small cell lung cancer treated with concurrent chemoradiotherapy [ J ]. Cancer Res Treat ,2015,2 (12) :2452-2455.
  • 7Schaake E, Rossi M, Buikhuisen W, et al. Differential motion be- tween mediastinal lymph nodes and primary tumor in radically ir- radiated lung cancer patients [ J ]. Int J Radiat Oncol Biol Phys 2014,90(4) :959-966.
  • 8Yoo I, Chung S, Park H, et al. Prognostic value of SUVmax and metabolic tumor volume on 18F-FDG PET/CT in early stage non- small cell lung cancer patients without LN metastasis [ J ]. Biomed Mater Eng,2014,24(6) :3091-3103.
  • 9Lee V, Chan W, Lee E, et al. Prognostic significance of standard- ized uptake value of lymph nodes on survival for stage III non- small cell lung cancer treated with definitive concurrent chemora- diotherapy[ J]. Am J Clin Oncal,2014,4(5 ) :42-47.
  • 10Feng W, Fu X, Cai X, et al. Patterns of local-regional failure in completely resected stage IIIA( N2 ) non-small cell lung cancer ca- ses:implications for postoperative radiation therapy clinical target volume design[ J]. Int J Radiat Oncol Biol Phys, 2014,88 (5) : 1100-1107.

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部